We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
Price data last checked 70 day(s) ago - refreshing...
Price History & Forecast
Last 21 days • 21 data points (No recent data available)
Price Distribution
Price distribution over 21 days • 1 price levels
Price Analysis
Most common price: £495 (21 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 21 days
Product Specifications
- Format
- paperback
- ASIN
- B00DVG07E4
- Domain
- Amazon UK
- Release Date
- 21 June 2013
- Listed Since
- 11 July 2013
Similar Products You Might Like
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia
£325.00
12 Jan 2026
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
£495.00
08 Jan 2026
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
£325.00
24 Feb 2026
97% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
£495.00
07 Jan 2026
97% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China
£495.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in Japan
£495.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Sepsis Therapeutics in Japan
£495.00
20 Feb 2026
95% match
The 2013-2018 Outlook for Human Growth Hormone Drugs in Japan
£495.00
08 Jan 2026
95% match
The 2023-2028 Outlook for Kinase Inhibitors in Japan
£495.00
24 Mar 2026
95% match
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan
£495.00
29 Jan 2026
95% match
The 2023-2028 Outlook for Therapeutic-Protein Biological Drugs in Japan
£495.00
12 Jan 2026
95% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan
£495.00
09 Jan 2026
95% match
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan
£495.00
25 Jan 2026
95% match
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in Japan
£495.00
13 Jan 2026
95% match
The 2013-2018 Outlook for Biofuel Enzymes in Japan
£495.00
10 Jan 2026
95% match
The 2023-2028 Outlook for Over the Counter Drugs in Japan
£495.00
11 Jan 2026
95% match
The 2023-2028 Outlook for Lipopeptide MRSA Drugs in Japan
£495.00
14 Jan 2026
95% match
The 2023-2028 Outlook for Anticoagulant Drugs in Japan
£495.00
13 Jan 2026
95% match
The 2023-2028 Outlook for Erythropoietin Drugs in Japan
£495.00
12 Jan 2026
95% match
The 2023-2028 Outlook for Protein Therapeutics in Japan
£495.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Japan
£495.00
08 Jan 2026
95% match
The 2023-2028 Outlook for OTC Drugs in Japan
£495.00
11 Jan 2026
95% match
The 2023-2028 Outlook for Anti-Malarial Drugs in Japan
£495.00
13 Dec 2025
95% match
The 2023-2028 Outlook for Anticoagulant Reversal Drugs in Japan
£495.00
23 Jan 2026